Disentangling the Variability of Exercise-induced Hypoalgesia: the Role of Circulatory Compounds

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Physical exercise is increasingly recognized as an effective treatment for chronic pain. Studies in humans and animals have shown that a single session of exercise induces a reduction of sensitivity to experimental painful stimuli lasting up to 45 minutes. In a recent study conducted in our laboratory, we found (1) that this exercise- induced hypoalgesia (EIH) is mainly driven by local changes in muscle nociceptor sensitivity within exercising muscles and (2) that EIH is consistent at a group level but fluctuates across sessions within participants. The first aim of this project is to uncover the mechanism(s) that drive EIH by investigating whether processes that could contribute to an exercise-induced change in muscle nociceptor sensitivity match the fluctuating pattern of EIH. Specifically, we will assess the possible involvement in EIH of the endocannabinoid system (eCB), Kynurenic acid (KynA, a circulating myokine that transiently increases after exercise), and β -endorphins (βE). Using a sample of 90 healthy males and females aged 18 to 30 years, we will measure sensitivity to blunt pressure stimuli before, immediately after, and 45 min after a 25-min cycling exercise to assess muscle nociceptor sensitivity at exercising (rectus femoris muscle) and non-exercising (ventral forearm) muscles. Blood samples will be collected at these time-points to measure plasma levels of eCBs, βE, and KynA. In addition, the effect of sex on EIH is controversial: some studies report no differences between males and females, while others report a greater effect in males or in females. Therefore, a secondary aim of this study is to explore potential sex differences in the manifestation and underlying mechanism(s) of EIH.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 30
Healthy Volunteers: t
View:

• Males, or females using hormonal contraception since ≥ 3 months.

• Aged between 18 and 30 years.

• Ability to provide written informed consent.

• Fluency in French or English.

• BMI between 17 and 30 kg/cm2.

Locations
Other Locations
Belgium
UCLouvain, Institute of neuroscience
RECRUITING
Brussels
Contact Information
Primary
André Mouraux, MD, PhD, Professor
andre.mouraux@uclouvain.be
+3227645447
Time Frame
Start Date: 2025-04-14
Estimated Completion Date: 2026-04-01
Participants
Target number of participants: 90
Treatments
Experimental: Exercise
Participants will complete three experimental sessions. In the first session, they will be asked to complete a set of questionnaires and to do a maximal exercise test. The next two sessions will be identical and will consist in blunt pressure sensitivity assessment-before (T0), immediately after (T1), and 45 min after (T2) a 25 min cycling exercise-at body parts involved (lower limb) and non-involved (upper limb, immobilized) in the exercise. Venous blood samples will be collected concomitantly to the sensory testing procedure.
Related Therapeutic Areas
Sponsors
Leads: Université Catholique de Louvain

This content was sourced from clinicaltrials.gov